ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1177

How Are Patients with Chronic Musculoskeletal Pain Conditions Being Managed Initially in the U.S.?

Debbie Ehrmann Feldman1, Lisa Carlesso2 and Richard Nahin3, 1Université de Montréal, Montréal, QC, Canada, 2School of Rehabilitation, Université de Montréal, Montreal, QC, Canada, 3NIH, Bethesda, MD

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Chronic pain, opioids and physical therapy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Health Services Research Poster II – ACR/ARHP

Session Type: ACR/ARHP Combined Abstract Session

Session Time: 9:00AM-11:00AM

Background/Purpose: Chronic musculoskeletal pain (e.g. back and neck pain, pain due to arthritis, leg pain, arm pain) affects up to 24% of the general population. Various approaches, both pharmacologic and nonpharmacologic, have been developed to manage chronic pain. With respect to pharmacological treatments, the overuse of opioid medications has led to an epidemic, even though many other evidence-based treatments are available and effective. Current guidelines recommend pharmacologic and nonpharmacologic treatments should be optimized before initiating a trial of opioids. The goal of this study was to explore initial clinical management of chronic musculoskeletal pain. We sought 1) to explore what treatments are prescribed at the initial visit with the physician for chronic musculoskeletal pain: i.e. medications, physical therapy, counseling; and 2) to describe factors associated with these prescribed treatments or services: more specifically clinician-related factors and patient-related factors.

Methods: We analyzed data from the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey-Out Patient Department (NAMCS) between 2007 and 2015. Visits with a new chronic musculoskeletal pain condition were identified using pre-determined diagnostic criteria. We documented the following treatment prescriptions: opioids, non-opioid pain medication, physical therapy, mental health counseling, stress management, injury prevention, exercise, diet, weight reduction and health education. We used logistic regression to explore associations between patient and provider factors and each of these prescription categories. Data were programmed using SUDAAN and descriptive statistics are presented. Logistic regression models to determine physician and patient-related factors associated with treatment prescription will be calculated.

Results: There were 19,341 initial visits over the 9-year period with a diagnosis of chronic musculoskeletal pain in the NAMCS database translating into 528,715,590 weighted initial visits. Mean age of patients at these initial visits was 49.4 years (95% confidence interval: 48.7-50.0) and 58.9% were female. The proportions of patients that were prescribed the following medications: NSAIDs, opioids, acetaminophen and muscle relaxants were 27.98, 19.15,16.8, and 10.19% respectively. The proportion of visits with referral to physical therapy was 9.73%, counseling for mental health 0.3%, stress management 0.92%, injury prevention 5.52%, exercise 10.60%, diet 6.47%, weight reduction 2.66%, and health education 14.03%. Ongoing analyses will elucidate patient and physician related factors associated with these various categories of treatment prescriptions.

Conclusion: There is a high frequency of visits for chronic musculoskeletal pain conditions. The frequency for opioid prescription was nearly double that of physical therapy. This result is troubling in view of the evidence and current guidelines that support non-opioid treatments for chronic musculoskeletal pain conditions.


Disclosure: D. Ehrmann Feldman, None; L. Carlesso, None; R. Nahin, None.

To cite this abstract in AMA style:

Ehrmann Feldman D, Carlesso L, Nahin R. How Are Patients with Chronic Musculoskeletal Pain Conditions Being Managed Initially in the U.S.? [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/how-are-patients-with-chronic-musculoskeletal-pain-conditions-being-managed-initially-in-the-u-s/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/how-are-patients-with-chronic-musculoskeletal-pain-conditions-being-managed-initially-in-the-u-s/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology